Jonny Mendoza-Castrejon

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Immunological reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia 38 (3) (2024)
Yan'an Li, Jonny Mendoza-Castrejon, Riddhi M Patel, Emily B Casey, Elisabeth Denby, David Bryder, Jeffrey A Magee
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression. Leukemia (2024)
Jonny Mendoza-Castrejon, Jeffrey A Magee
Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. Immunological reviews (2023)
Jonny Mendoza-Castrejon, Jeffrey A Magee
Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. Immunological reviews (2023)
Yan'an Li, Wei Yang, Riddhi M Patel, Emily B Casey, Elisabeth D Denby, Jonny Mendoza-Castrejon, Priscilla Rodriguez-Lopez, Jeffrey A Magee
FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation. Blood (2022)